Report cover image

China Injectable Drug Delivery Devices Market Size-By Type of Devices, By Therapeutic Application, By Usage Pattern, By Site of Delivery-Regional Outlook, Competitive Strategies and Segment Forecast to 2032

Publisher SPER Market Research Pvt. Ltd.
Published Feb 06, 2023
Length 231 Pages
SKU # SPER18038231

Description

China Injectable Drug Delivery Devices Market Size-By Type of Devices, By Therapeutic Application, By Usage Pattern, By Site of Delivery-Regional Outlook, Competitive Strategies and Segment Forecast to 2032


China Injectable Drug Delivery Devices Market Overview

According to SPER Market Research, the China Injectable Drug Delivery Devices Market is estimated to reach USD 235.46 billion by 2032 with a CAGR of 18.23%. The delivery and transportation of therapeutic medicine to a patient's body is accomplished using injectable devices. The equipment used to deliver injectable drugs comes in a wide variety, including traditional syringes, needle-free injectors, auto-injectors, and pen injectors. Devices for subcutaneous drug delivery are used to treat a variety of chronic and infectious disorders.

Impact of COVID-19 on the China Injectable Drug Delivery Devices Market

Covid-19 is a highly contagious illness that mostly affects people's respiratory systems. The covid19 is affecting people all throughout the world. With the exception of the pharmaceutical industry, it has had a negative impact on the operation of every industry. There is an increased need for ventilators, testing supplies, medications, vaccines, and oxygen cylinders compared to before the global pandemic. The demand for injectable devices and other healthcare products increased last year, which led to a boom in the market for injectable medication delivery devices.

Scope of the Report:

Report Metric Details
Market size available for years 2019-2032
Base year considered 2021
Forecast period 2022-2032

Segments covered By Type of Devices, By Therapeutic Application, By Usage Pattern, By Site of Delivery

Regions covered North China, Northeast China, East China, South China, Central China, Southwest China, Northwest China.

Companies Covered Baxter, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Gerresheimer AG, GSK plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi.

China Injectable Drug Delivery Devices Market Segmentation:

By Type of Devices: Based on the Type of Devices, China Injectable Drug Delivery Devices Market is segmented as; Conventional Injection Devices, Self-Injection Devices

By Therapeutic Application: Based on the Therapeutic Application, China Injectable Drug Delivery Devices Market is segmented as; Autoimmune Diseases, Hormonal Disorders, Cancer

By Region: The China Injectable Drug Delivery Devices Market is divided into seven regions North China, Northeast China, East China, South China, Central China, Southwest China, and Northwest China.

Table of Contents

231 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the China Injectable Drug Delivery Devices Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 China Injectable Drug Delivery Devices Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in China Injectable Drug Delivery Devices Market
7. China Injectable Drug Delivery Devices Market, By Type of Devices, 2019-2032 (USD Million)
7.1. Conventional Injection Devices
7.2. Self-Injection Devices
8. China Injectable Drug Delivery Devices Market, By Therapeutic Application, 2019-2032 (USD Million)
8.1. Autoimmune Diseases
8.2. Hormonal Disorders
8.3. Cancer
9. China Injectable Drug Delivery Devices Market, By Usage Pattern, 2019-2032 (USD Million)
9.1. Curative pattern
9.2. Immunization
10. China Injectable Drug Delivery Devices Market, By Site of Delivery, 2019-2032 (USD Million)
10.1. Intramuscular
10.2. Subcutaneous
10.3. Intra Dermal
11. China Injectable Drug Delivery Devices Market, By Region, 2019-2032 (USD Million)
11.1. China Injectable Drug Delivery Devices Market Size and Market Share by Region (2019-2025)
11.2. China Injectable Drug Delivery Devices Market Size and Market Share by Region (2026-2032)
11.3. North China
11.4. Northeast China
11.5. East China
11.6. South China 
11.7. Central China
11.8. Southwest China
11.9. Northwest China
12. Company Profiles
12.1. Baxter
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Becton
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Dickinson and Company
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. F. Hoffmann-La Roche AG
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Gerresheimer AG
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. GSK plc
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Merck & Co. Inc.
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Novartis AG
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Pfizer Inc.
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Sanofi
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Teva Pharmaceutical Industries Ltd
12.11.1. Company details
12.11.2. Financial outlook
12.11.3. Product summary
12.11.4. Recent developments
13. List of Abbreviations
14. Reference Links
15. Conclusion
16. Research Scope

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us